{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:48:29Z","timestamp":1780066109563,"version":"3.54.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,23]],"date-time":"2010-10-23T00:00:00Z","timestamp":1287792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s11064-010-0289-x","type":"journal-article","created":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T03:47:04Z","timestamp":1287719224000},"page":"177-186","source":"Crossref","is-referenced-by-count":39,"title":["Antiparkinsonian Effects of Aqueous Methanolic Extract of Hyoscyamus niger Seeds Result From its Monoamine Oxidase Inhibitory and Hydroxyl Radical Scavenging Potency"],"prefix":"10.1007","volume":"36","author":[{"given":"T.","family":"Sengupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Vinayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Nagashayana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gowda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Jaisankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. P.","family":"Mohanakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,23]]},"reference":[{"key":"289_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ptr.1165","volume":"18","author":"M Sawant","year":"2004","unstructured":"Sawant M, Isaac JC, Narayanan S (2004) Analgesic studies on total alkaloids and alcohol extracts of Eclipta alba (Linn.) Hassk. Phytotheyapt Res 18:111\u2013113","journal-title":"Phytotheyapt Res"},{"key":"289_CR2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.plaphy.2008.09.004","volume":"47","author":"N El Jaber-Vazdekis","year":"2009","unstructured":"El Jaber-Vazdekis N, Gonz\u00e1lez C, Ravelo AG et al (2009) Cloning, characterization and analysis of expression profiles of a cDNA encoding a hyoscyamine 6-beta-hydroxylase (H6H) from Atropa baetica Willk. Plant Physiol Biochem 47:20\u201325","journal-title":"Plant Physiol Biochem"},{"key":"289_CR3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1472-8206.2007.00561.x","volume":"22","author":"AH Gilani","year":"2008","unstructured":"Gilani AH, Khan AU, Raoof M et al (2008) Gastrointestinal, selective airways and urinary bladder relaxant effects of Hyoscyamus reticulatus are mediated through dual blockade of muscarinic receptors and Ca2+ channels. Fundam Clin Pharmacol 22:87\u201399","journal-title":"Fundam Clin Pharmacol"},{"key":"289_CR4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/000348940211100612","volume":"111","author":"IA Ramoutsaki","year":"2002","unstructured":"Ramoutsaki IA, Papadakis CE, Ramoutsakis IA et al (2002) Therapeutic methods used for otolaryngological problems during the Byzantine period. Ann Otol Rhinol Laryngol 111:553\u2013557","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"289_CR5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1021\/np010073b","volume":"65","author":"CY Ma","year":"2002","unstructured":"Ma CY, Liu WK, Che CT (2002) Lignanamides and nonalkaloidal components of Hyoscyamus niger seeds. J Nat Prod 65:206\u2013209","journal-title":"J Nat Prod"},{"key":"289_CR6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1177\/014107689108400814","volume":"84","author":"M Gouriedevi","year":"1991","unstructured":"Gouriedevi M, Ramu MG, Venkararam BS (1991) Treatment of Parkinson\u2019s disease in \u2018Ayurveda\u2019 (ancient Indian system of Medicine): discussion paper. J R Soc Med 84:491\u2013492","journal-title":"J R Soc Med"},{"key":"289_CR7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0022-510X(00)00329-4","volume":"176","author":"N Nagashayana","year":"2000","unstructured":"Nagashayana N, Sankarankutty P, Nampoothiri MR et al (2000) Association of L-DOPA with recovery following Ayurveda medication in Parkinson\u2019s disease. J Neurol Sci 176:124\u2013127","journal-title":"J Neurol Sci"},{"key":"289_CR8","first-page":"308","volume":"22","author":"HM Reza","year":"2009","unstructured":"Reza HM, Mohammad H, Golnaz E et al (2009) Effect of methanolic extract of Hyoscyamus reticulatus L. on the seizure induced by picritoxin in mice. Pak J Pharmacol Sci 22:308\u2013312","journal-title":"Pak J Pharmacol Sci"},{"key":"289_CR9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1358\/mf.2008.30.4.1186075","volume":"30","author":"AU Khan","year":"2008","unstructured":"Khan AU, Gilani AH (2008) Cardiovascular inhibitory effects of Hyoscyamus reticulatus. Methods Find Exp Clin Pharmacol 30:295\u2013300","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"289_CR10","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1136\/jnnp.2003.028761","volume":"75","author":"R Katzenschlager","year":"2004","unstructured":"Katzenschlager R, Evans A, Manson A et al (2004) Mucuna pruriens in Parkinson\u2019s disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry 75:1672\u20131677","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"289_CR11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ptr.1407","volume":"18","author":"BV Manyam","year":"2004","unstructured":"Manyam BV, Dhanasekaran M, Hare TA (2004) Effect of antiparkinson drug HP-200 (Mucuna pruriens) on the central monoaminergic neurotransmitters. Phytotherapy Res 18:97\u2013101","journal-title":"Phytotherapy Res"},{"key":"289_CR12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jep.2009.08.003","volume":"125","author":"SR Sankar","year":"2009","unstructured":"Sankar SR, Manivasagam T, Sankar V et al (2009) Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson\u2019s disease model mouse. J Ethnopharmacol 125:369\u2013373","journal-title":"J Ethnopharmacol"},{"key":"289_CR13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.2478\/s11658-007-0015-0","volume":"12","author":"SR Sankar","year":"2007","unstructured":"Sankar SR, Manivasagam T, Krishnamurti A et al (2007) The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: an analysis of behavioral and biochemical variables. Cell Mol Biol Lett 12:473\u2013481","journal-title":"Cell Mol Biol Lett"},{"key":"289_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1191\/0960327105ht509oa","volume":"24","author":"M Ahmad","year":"2005","unstructured":"Ahmad M, Saleem S, Ahmad AS et al (2005) Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol 24:137\u2013147","journal-title":"Hum Exp Toxicol"},{"key":"289_CR15","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1046\/j.1471-4159.1994.62051906.x","volume":"62","author":"N Mitra","year":"1994","unstructured":"Mitra N, Mohanakumar KP, Ganguly DK (1994) Resistance of golden hamster to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine: relationship with low levels of regional monoamine oxidase-B. J Neurochem 62:1906\u20131912","journal-title":"J Neurochem"},{"key":"289_CR16","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/00001756-200004070-00037","volume":"11","author":"M Sedelis","year":"2000","unstructured":"Sedelis M, Hofele K, Auburger GW, Morgan S, Huston JP, Schwarting RK (2000) Evidence for resistance to MPTP in C57BL\/6 \u00d7 BALB\/c F1 hybrids as compared with their progenitor strains. Neuroreport 11:1093\u20131096","journal-title":"Neuroreport"},{"key":"289_CR17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/WNR.0b013e32832aa95b","volume":"20","author":"NM Filipov","year":"2009","unstructured":"Filipov NM, Norwood AB, Sistrunk SC (2009) Strain-specific sensitivity to MPTP of C57BL\/6 and BALB\/c mice is age dependent. Neuroreport 20:713\u2013717","journal-title":"Neuroreport"},{"key":"289_CR18","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/0028-3908(89)90015-4","volume":"28","author":"JA Hoskins","year":"1989","unstructured":"Hoskins JA, Davis LJ (1989) The acute effect on levels of catecholamines and metabolites in brain, of a single dose of MPTP in 8 strains of mice. Neuropharmacology 28:1389\u20131397","journal-title":"Neuropharmacology"},{"key":"289_CR19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00001756-199209000-00014","volume":"3","author":"LG Chia","year":"1992","unstructured":"Chia LG, Liu SP, Lee EH (1992) Differential effects of deprenyl and MPTP on catecholamines and activity in BALB\/c mice. Neuroreport 3:777\u2013780","journal-title":"Neuroreport"},{"key":"289_CR20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3940(03)00577-9","volume":"346","author":"S Samantaray","year":"2003","unstructured":"Samantaray S, Mohanakumar KP (2003) Calcium channel agonist, (\u00b1)-Bay K8644, causes an immediate increase in the striatal 1-methyl-4-phenylpyridinium level following systemic administration of the dopaminergic neurotoxin, 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in Balb\/c mice. Neurosci Lett 346:69\u201372","journal-title":"Neurosci Lett"},{"key":"289_CR21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbr.2005.04.011","volume":"163","author":"R Haobam","year":"2005","unstructured":"Haobam R, Sindhu KM, Chandra G, Mohanakumar KP (2005) Swim-test as a function of motor impairment in MPTP model of Parkinson\u2019s disease: a comparative study in two mouse strains. Behav Brain Res 163:159\u2013167","journal-title":"Behav Brain Res"},{"key":"289_CR22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0361-9230(92)90035-V","volume":"28","author":"N Mitra","year":"1992","unstructured":"Mitra N, Mohanakumar KP, Ganguly DK (1992) Dissociation of serotoninergic and dopaminergic components in acute effects of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in mice. Brain Res Bull 28:355\u2013364","journal-title":"Brain Res Bull"},{"key":"289_CR23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fasebj.12.10.905","volume":"12","author":"D Muralikrishnan","year":"1998","unstructured":"Muralikrishnan D, Mohanakumar KP (1998) Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity in mice. FASEB J 12:905\u2013912","journal-title":"FASEB J"},{"key":"289_CR24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0006-8993(00)02189-2","volume":"864","author":"KP Mohanakumar","year":"2000","unstructured":"Mohanakumar KP, Muralikrishnan D, Thomas B (2000) Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity. Brain Res 864:281\u2013290","journal-title":"Brain Res"},{"key":"289_CR25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0160-5402(85)90021-X","volume":"13","author":"A Morinan","year":"1985","unstructured":"Morinan A, Garratt HM (1985) An improved fluorimetric assay for brain monoamine oxidase. J Pharmacol Methods 13:213\u2013223","journal-title":"J Pharmacol Methods"},{"key":"289_CR26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"289_CR27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1749-6632.1994.tb21828.x","volume":"738","author":"KP Mohanakumar","year":"1994","unstructured":"Mohanakumar KP, de Bartolomeis A, Wu RM et al (1994) Ferrous-citrate complex and nigral degeneration: evidence for free-radical formation and lipid peroxidation. Ann N Y Acad Sci 738:392\u2013399","journal-title":"Ann N Y Acad Sci"},{"key":"289_CR28","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11064-007-9473-z","volume":"33","author":"R Banerjee","year":"2008","unstructured":"Banerjee R, Saravanan KS, Thomas B et al (2008) Evidence for hydroxyl radical scavenging action of nitric oxide donors in the protection against 1-methyl-4-phenylpyridinium-induced neurotoxicity in rats. Neurochem Res 33:985\u2013995","journal-title":"Neurochem Res"},{"key":"289_CR29","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.neuint.2007.10.012","volume":"52","author":"B Thomas","year":"2008","unstructured":"Thomas B, Saravanan KS, Mohanakumar KP (2008) In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole. Neurochem Int 52:990\u20131001","journal-title":"Neurochem Int"},{"key":"289_CR30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00726-007-0571-7","volume":"35","author":"AK Navneet","year":"2008","unstructured":"Navneet AK, Appukuttan TA, Pandey M (2008) Taurine fails to protect against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced striatal dopamine depletion in mice. Amino Acids 35:457\u2013461","journal-title":"Amino Acids"},{"key":"289_CR31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0891-5849(91)90052-5","volume":"10","author":"B Halliwell","year":"1991","unstructured":"Halliwell B, Kaur H, Ingelman-Sundberg M (1991) Hydroxylation of salicylate as an assay for hydroxyl radiocals: a cautionary note. Free Radic Biol Med 10:439\u2013441","journal-title":"Free Radic Biol Med"},{"key":"289_CR32","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1021\/np9902082","volume":"62","author":"CY Ma","year":"1999","unstructured":"Ma CY, William ID, Che CT (1999) Withanolides from Hyoscyamus niger seeds. J Nat Prod 62:1445\u20131447","journal-title":"J Nat Prod"},{"key":"289_CR33","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1248\/cpb.54.538","volume":"54","author":"B Sajeli","year":"2006","unstructured":"Sajeli B, Sahai M, Suessmuth R et al (2006) Hyosgerin, a new optically active coumarinolignan, from the seeds of Hyoscyamus niger. Chem Pharm Bull 54:538\u2013541","journal-title":"Chem Pharm Bull"},{"key":"289_CR34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/14786410802113961","volume":"23","author":"AS Begum","year":"2009","unstructured":"Begum AS, Verma S, Sahai M et al (2009) Hyoscyamal, a new tetrahydrofurano lignan from Hyoscyamus niger Linn. Nat Prod Res 23:595\u2013600","journal-title":"Nat Prod Res"},{"key":"289_CR35","first-page":"10","volume-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics","author":"JH Brown","year":"2001","unstructured":"Brown JH, Taylor P (2001) Muscarinic receptors agonist and antagonists. In: Hardman JG, Limbird LE, Gilman\u2019s AG (eds) Goodman and Gilman\u2019s the pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York, p 10","edition":"10"},{"key":"289_CR36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1600-0404.1995.tb00443.x","volume":"91","author":"M Asahina","year":"1995","unstructured":"Asahina M, Shinotoh H, Hirayama K et al (1995) Hypersensitivity of cortical muscarinic receptors in Parkinson\u2019s disease demonstrated by PET. Acta Neurol Scand 91:437\u2013443","journal-title":"Acta Neurol Scand"},{"key":"289_CR37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.tins.2004.06.008","volume":"27","author":"M Quik","year":"2004","unstructured":"Quik M (2004) Smoking, nicotine and Parkinson\u2019s disease. Trends Neurosci 27:561\u2013568","journal-title":"Trends Neurosci"},{"key":"289_CR38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0006-8993(94)91032-4","volume":"636","author":"R Rodriguez-Puertas","year":"1994","unstructured":"Rodriguez-Puertas R, Pazos A, Pascual J (1994) Cholinergic markers in degenerative parkinsonism: autoradiographic demonstration of high-affinity choline uptake carrier hyperactivity. Brain Res 636:327\u2013332","journal-title":"Brain Res"},{"key":"289_CR39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrd2087","volume":"5","author":"AH Schapira","year":"2006","unstructured":"Schapira AH, Bezard E, Brotchie J et al (2006) Novel pharmacological targets for the treatment of Parkinson\u2019s disease. Nat Rev Drug Discov 5:845\u2013854","journal-title":"Nat Rev Drug Discov"},{"key":"289_CR40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2174\/187152708786441867","volume":"7","author":"OM Abdel-Salam","year":"2008","unstructured":"Abdel-Salam OM (2008) Drugs used to treat Parkinson\u2019s disease, present status and future directions. CNS Neurol Disord Drug Targets 7:321\u2013342","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"289_CR41","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2165\/00003495-199957060-00001","volume":"57","author":"RL Rodnitzky","year":"1999","unstructured":"Rodnitzky RL (1999) Can calcium antagonists provide a neuroprotective effect in Parkinson\u2019s disease? Drugs 57:845\u2013849","journal-title":"Drugs"},{"key":"289_CR42","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2165\/00023210-200317100-00004","volume":"17","author":"S Mandel","year":"2003","unstructured":"Mandel S, Gr\u00fcnblatt E, Riederer P et al (2003) Neuroprotective strategies in Parkinson\u2019s disease: an update on progress. CNS Drugs 17:729\u2013762","journal-title":"CNS Drugs"},{"key":"289_CR43","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.1994.tb21806.x","volume":"738","author":"RM Wu","year":"1994","unstructured":"Wu RM, Mohanakumar KP, Murphy DL et al (1994) Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline). Ann N Y Acad Sci 738:214\u2013221","journal-title":"Ann N Y Acad Sci"},{"key":"289_CR44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0006-8993(99)02202-7","volume":"852","author":"B Thomas","year":"2000","unstructured":"Thomas B, Muralikrishnan D, Mohanakumar KP (2000) In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in mice. Brain Res 852:221\u2013224","journal-title":"Brain Res"},{"key":"289_CR45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0006-8993(02)04174-4","volume":"966","author":"K Sairam","year":"2003","unstructured":"Sairam K, Saravanan KS, Banerjee R et al (2003) Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats. Brain Res 966:245\u2013252","journal-title":"Brain Res"},{"key":"289_CR46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1749-6632.2002.tb04083.x","volume":"962","author":"KP Mohanakumar","year":"2002","unstructured":"Mohanakumar KP, Thomas B, Sharma SM et al (2002) Nitric oxide: an antioxidant and neuroprotector. Ann N Y Acad Sci 962:389\u2013401","journal-title":"Ann N Y Acad Sci"},{"key":"289_CR47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/syn.10239","volume":"50","author":"D Muralikrishnan","year":"2003","unstructured":"Muralikrishnan D, Samantaray S, Mohanakumar KP (2003) D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity. Synapse 50:7\u201313","journal-title":"Synapse"},{"key":"289_CR48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1600-079X.2003.00096.x","volume":"36","author":"B Thomas","year":"2004","unstructured":"Thomas B, Mohanakumar KP (2004) Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in the mouse nigrostriatum. J Pineal Res 36:25\u201332","journal-title":"J Pineal Res"},{"key":"289_CR49","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0197-0186(03)00170-0","volume":"44","author":"DS Maharaj","year":"2004","unstructured":"Maharaj DS, Saravanan KS, Maharaj H et al (2004) Acetaminophen and aspirin inhibit superoxide anion generation and lipid peroxidation, and protect against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats. Neurochem Int 44:355\u2013360","journal-title":"Neurochem Int"},{"key":"289_CR50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2004.11.010","volume":"375","author":"VH Knaryan","year":"2005","unstructured":"Knaryan VH, Samantaray S, Galoyan AA (2005) A synthetic human proline-rich-polypeptide enhances hydroxyl radical generation and fails to protect dopaminergic neurons against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced toxicity in mice. Neurosci Lett 375:187\u2013191","journal-title":"Neurosci Lett"},{"key":"289_CR51","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/0031-9422(75)83057-3","volume":"14","author":"S Ghosal","year":"1975","unstructured":"Ghosal S, Rama B, Chauhan PS, Mehta R (1975) Alkaloids of Sida cordifolia. Phytochemistry 14:830\u2013832","journal-title":"Phytochemistry"},{"key":"289_CR52","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuint.2010.07.013","volume":"57","author":"T Sengupta","year":"2010","unstructured":"Sengupta T, Mohanakumar KP (2010) 2-Phenylethylamine, a constituent of chocolate and wine, causes mitochondrial complex-I inhibition, generation of hydroxyl radicals and depletion of striatal biogenic amines leading to psycho-motor dysfunctions in Balb\/c mice. Neurochem Int 57:637\u2013646","journal-title":"Neurochem Int"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-010-0289-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-010-0289-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-010-0289-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T17:17:06Z","timestamp":1711905426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-010-0289-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,23]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["289"],"URL":"https:\/\/doi.org\/10.1007\/s11064-010-0289-x","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,23]]}}}